Opinion: Does marijuana cause psychosis? The answer is complicated February 9, 2024 AggregatedNews Op-Ed, Opinions, Science and Technology 0 Comments Of the many harms attributed to cannabis use, few have garnered as much attention as the frightening association of cannabis with psychosis. From the 1936 exploitation film “Reefer Madness” to a recent article in the Wall Street Journal, the media has… Read More→
Cultivating Fair Cannabis Pricing: A Deeper Look Beyond THC December 19, 2023 Tyler McCain News & Insights, Op-Ed, Opinions 0 Comments By Tyler McCain Cannabis flower is multifaceted, and enjoyment is highly personalized. Unfortunately, most manufacturers and dispensaries attempt to simplify cannabis to a one-dimensional metric: THC content. This single-minded focus on tetrahydrocannabinol, or THC, keeps cannabis consumers from accurately determining… Read More→
From Schedule I to Schedule III: The Path to Success? September 7, 2023 Jacques Santucci Descheduling or Rescheduling Marijuana, Op-Ed 1 Comment In a significant development, the U.S. Department of Health and Human Services (HHS) officially recommended on August, 30, 2023, that the U.S. Drug Enforcement Agency (DEA) reclassify marijuana from a Schedule I to Schedule III drug under the Controlled Substances Act.… Read More→
Reflections On the recent Oklahoma Medical Marijuana Authority Survey August 16, 2023 Chip Paul Oklahoma, Op-Ed, Opinions 0 Comments By Chip Paul Recently a survey has made the rounds in cannabis circles regarding Oklahoma and the “oversupply” issue. It is dramatic and very eye catching and concludes that Oklahoma is oversupplied by 32 times. When you add to that shocking result the fact… Read More→
Cannabis & Public Relations: Why Federal Legalization Will Be a Game Changer August 15, 2023 Alex Rush Marketing, Op-Ed 1 Comment By Alex Rush, Account Director & Senior Cannabis Strategist, Rosen Group Legal cannabis markets are rapidly emerging across the country; as of summer 2023, 23 states have implemented adult-use markets, while another 24 have medical-only cannabis markets (though some markets… Read More→
Legalizing Marijuana Is a Big Mistake May 17, 2023 AggregatedNews Opinions 0 Comments By Ross Douthat Of all the ways to win a culture war, the smoothest is to just make the other side seem hopelessly uncool. So it’s been with the march of marijuana legalization: There have been moral arguments about the… Read More→
Dr. Leana Wen is Wrong; We Should Be Celebrating Cannabis Use April 27, 2023 Tom Hymes News & Insights, Opinions 3 Comments Reading Dr. Leana Wen’s Washington Post opinion piece this week, “We should not be celebrating marijuana use,” I could not help but think back to 2015, when I attended an early MJBizCon show at one of Chicago’s great hotels. While… Read More→
How the cannabis industry will be the blueprint for future of work April 19, 2023 Sloane Barbour HR and Staffing, Op-Ed, Science and Technology 0 Comments By Sloane Barbour As more states legalize cannabis, the industry is expanding at a breathtaking pace. With much to look forward to and a building sense of enthusiasm, this means that job development is ramping up with thousands of jobs… Read More→
How Regtech Is Simplifying Cannabis Compliance April 19, 2023 Marion Mariathasan Banking, Finance & Real Estate, Compliance, Compliance and Regulations, Insurance, Op-Ed, Science and Technology 0 Comments By Marion Mariathasan There is no doubt that 2023 has been a bumpy start for many in the cannabis sector. A bear market is obliterating company valuations. Federal reforms are moving at a glacially slow pace. Inflation continues to choke… Read More→
Growth Opportunities for CannaGenetics in Germany’s Burgeoning Market March 29, 2023 Niklas Kouparanis Op-Ed 0 Comments By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder In 2022, Germany made significant steps toward making adult-use cannabis legalization a reality. Last October, Germany’s Health Minister Karl Lauterbach released a cornerstone paper outlining plans for the legal sale and consumption… Read More→
FDA is correct…we absolutely DO need a new Cannabinoid Regulatory Agency… February 1, 2023 Lezli Engelking Hemp Policy & Legal, Op-Ed 1 Comment As any American not living under a rock knows, the US Food and Drug Administration (FDA) is struggling to meet their current responsibilities in any effective or meaningful way. Be it baby formula, recalls, or conflicts of interest, FDA’s value… Read More→
The Problem with Big Marijuana is Not Hemp January 9, 2023 Cynthia Cabrera Hemp Policy & Legal, Op-Ed 2 Comments By Cynthia Cabrera It comes as no surprise that Steve Schain’s December 11 article, “Cannabis’ Plummeting Price-Per-Pound and the Rise of Delta-8 THC,” blames the marijuana industry’s woes on new cannabinoids like Delta-8, stating “hemp-derived THC (Delta-8 THC) is cutting… Read More→
New Year, New Steps Towards Adult-Use Cannabis for Germany January 4, 2023 Niklas Kouparanis Germany, Op-Ed 0 Comments By Niklas Kouparanis, Bloomwell Group CEO and Co-Founder In October 2022, Germany’s Health Minister Karl Lauterbach released a cornerstone paper outlining plans for the legal sale and consumption of cannabis in the country. While this is a big step forward… Read More→
Using Data and Insights to Create Winning Cannabis Markets December 7, 2022 Roy Bingham Marketing, Op-Ed 0 Comments By Roy Bingham With nearly 80% of adults open to consuming cannabis in fully legal states and cannabis regulations loosening across the country, markets are continuing to develop at an ever-increasing rate. However, current legal markets differ greatly in how… Read More→
As Michigan Cannabis Industry Matures, Demand for Capital Surges December 5, 2022 Ray Zillgitt Banking, Finance & Real Estate, Op-Ed 0 Comments It has been a tumultuous year for marijuana in Michigan. Since the state legalized the recreational use of cannabis in 2018, the industry has seen a glut of applications for new facilities. The vast majority have been approved. As new players entered… Read More→